Neural Mechanisms in Cariorenal Regulation
心血管调节的神经机制
基本信息
- 批准号:7596574
- 负责人:
- 金额:$ 32.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-15 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The sympathetic nervous system plays an important role in the pathogenesis of hypertension, yet the precise
determinants of sympathetic activation are unresolved. Furthermore, the efferent mechanisms that account for
long-term sympathetically-induced alterations in arterial pressure are unclear. In this regard, there is
considerable controversy as to whether alterations in renal excretory function are of paramount importance in
mediating the chronic effects of the nervous system on arterial pressure. In short, progress in understanding
the above issues has been limited by the lack of clinical and experimental methods for critically studying
sympathetic function in the chronic regulation of arterial pressure. Because of the crucial role of the baroreflex
in acute regulation of arterial pressure, there has been a long-standing interest in the possibility that
baroreflexes might chronically influence the level of sympathetic activity and arterial pressure in hypertension.
The potential importance of such a relationship has been highlighted by clinical observations demonstrating
that the sympathetic arm of the baroreflex is impaired in primary hypertension. However, because the
baroreflex resets in the direction of the ambient pressure, a role for the baroreflex in long-term pressure control
is often discounted. On the other hand, because of technical limitations, it is important to emphasize that there
is little empirical evidence from chronic studies that supports the notion that baroreflex resetting is complete in
hypertension. In fact, recent innovative studies in animals with experimentally-induced hypertension suggest
that the baroreflex does not totally reset and has sustained sympathoinhibitory effects in hypertension. These
studies further indicate baroreflex activation chronically suppresses renal sympathetic nerve activity and
promotes sodium excretion, responses expected to attenuate the severity of hypertension. The relevance of
these studies to clinical hypertension, however, is limited by their relatively short duration (most commonly one
week). In the proposed studies, we will use a novel approach to evaluate several aspects of baroreflex function
over at least 3 weeks of controlled baroreflex activation. We will use a combination of sophisticated techniques
in chronically instrumented dogs to determine whether the central nervous system contributes to chronic
resetting of the baroreflex and whether chronic activation of the baroreflex does indeed have sustained effects
to inhibit renal sympathetic nerve activity and promote sodium excretion. To achieve these goals, the carotid
baroreflex will be chronically activated by electrical stimulation of the carotid sinuses. Chronic electrical
activation of the carotid baroreflex leads to sustained suppression of sympathetic activity and arterial pressure
and is an ideal technique for determining the importance of central resetting in attenuating the
sympathoinhibition induced by increased baroreceptor activity because it allows for precise control of central
afferent input patterns. Additionally, in combination with other measures, this methodology permits direct
evaluation of the chronic effects of baroreflex activation on renal sympathetic outflow and excretory function.
Isotope dilution methodology will be used in these studies to determine whole body and renal norepinephrine
spillover to plasma as indices of central and renal specific sympathetic outflow. These studies will provide
unique insight into the chronic functional effects of the baroreflex in hypertension and the importance of the
kidneys in mediating long-term changes in-arterial pressure during alterations in central sympathetic outflow.
交感神经系统在高血压的发病机制中起着重要作用,但其发病机制尚不明确
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS E LOHMEIER其他文献
THOMAS E LOHMEIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS E LOHMEIER', 18)}}的其他基金
NERVOUS SYSTEM MECHANISMS IN CIRCULATORY CONTROL
循环控制中的神经系统机制
- 批准号:
6242327 - 财政年份:1997
- 资助金额:
$ 32.39万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 32.39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 32.39万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 32.39万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 32.39万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 32.39万 - 项目类别:
Idea to Innovation














{{item.name}}会员




